{"pmid":32293020,"title":"[Palliation in patients with severe COVID-19].","text":["[Palliation in patients with severe COVID-19].","Coronavirus Disease 2019 (COVID-19) can cause severe respiratory failure and distressing symptoms including fever, cough, breathlessness and anxiety. Symptomatic (palliative) treatment is of fundamental importance both in conjuncture with life-sustaining interventions and in end of life care. Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine). Top priorities include precautions to protect staff and people at-risk from infection and planning how to provide adequate treatment for each individual depending on setting, including palliative care.","Lakartidningen","Ekstrom, Magnus","Dahlander, Bengt","32293020"],"abstract":["Coronavirus Disease 2019 (COVID-19) can cause severe respiratory failure and distressing symptoms including fever, cough, breathlessness and anxiety. Symptomatic (palliative) treatment is of fundamental importance both in conjuncture with life-sustaining interventions and in end of life care. Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine). Top priorities include precautions to protect staff and people at-risk from infection and planning how to provide adequate treatment for each individual depending on setting, including palliative care."],"journal":"Lakartidningen","authors":["Ekstrom, Magnus","Dahlander, Bengt"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293020","week":"202016|Apr 13 - Apr 19","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1664266295752785920,"score":8.233237,"similar":[{"pmid":32133829,"title":"[Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].","text":["[Analysis of bronchoscope-guided tracheal intubation in 12 cases with COVID-19 under the personal protective equipment with positive pressure protective hood].","Endotracheal intubation is an independent risk factor for respiratory infectious diseases. We conducted a retrospective study in 12 cases with COVID-19 who underwent endotracheal intubation at ICU of the Guangzhou eighth hospital from January 20 to February 10, 2020. The intubation procedure, anesthetic regimen, and complication were collected and analyzed. The 9 healthcare workers who involved in intubation received virus nucleic acid test and 14 days temperature monitoring. All 12 patients were successfully intubated under the guidance of bronchoscope, without any complications. Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure. The 9 healthcare workers were protected under the Personal Protective Equipment(PPE) with positive pressure protective hood. The detection of oropharyngeal swab virus nucleic acid were negative in all 9 healthcare workers, none of them had fever or any respiratory symptoms. The PPE with positive pressure protective hood should be needed to perform bronchoscope-guided endotracheal intubation in patients with COVID-19, it could strengthen to protect healthcare workers from virus exposure.","Zhonghua Jie He He Hu Xi Za Zhi","Cai, S J","Wu, L L","Chen, D F","Li, Y X","Liu, Y J","Fan, Y Q","Du, S H","Huang, H","Liu, N","Cheng, L L","Deng, X L","Li, S Y","32133829"],"abstract":["Endotracheal intubation is an independent risk factor for respiratory infectious diseases. We conducted a retrospective study in 12 cases with COVID-19 who underwent endotracheal intubation at ICU of the Guangzhou eighth hospital from January 20 to February 10, 2020. The intubation procedure, anesthetic regimen, and complication were collected and analyzed. The 9 healthcare workers who involved in intubation received virus nucleic acid test and 14 days temperature monitoring. All 12 patients were successfully intubated under the guidance of bronchoscope, without any complications. Midazolam, Propofol and Morphine or fentanyl were used for sedation and analgesia, avoiding patients cough and agitated during the procedure. The 9 healthcare workers were protected under the Personal Protective Equipment(PPE) with positive pressure protective hood. The detection of oropharyngeal swab virus nucleic acid were negative in all 9 healthcare workers, none of them had fever or any respiratory symptoms. The PPE with positive pressure protective hood should be needed to perform bronchoscope-guided endotracheal intubation in patients with COVID-19, it could strengthen to protect healthcare workers from virus exposure."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Cai, S J","Wu, L L","Chen, D F","Li, Y X","Liu, Y J","Fan, Y Q","Du, S H","Huang, H","Liu, N","Cheng, L L","Deng, X L","Li, S Y"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32133829","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112147-20200222-00153","keywords":["Bronchoscope-guided","COVID-19","Endotracheal intubation","Positive pressure protective hood"],"source":"PubMed","locations":["Morphine","analgesia","Guangzhou"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"e_drugs":["Midazolam","Propofol","Morphine","Fentanyl"],"_version_":1663352134230343680,"score":190.64992},{"pmid":32291505,"title":"German recommendations for critically ill patients with COVID19.","text":["German recommendations for critically ill patients with COVID19.","Since December 2019, a novel coronavirus (severe acute respiratory syndrome-coronavirus 2, SARS-CoV-2) has rapidly spread around the world resulting in an acute respiratory illness pandemic. The majority of patients presents with mild symptoms of coronavirus disease 2019 (COVID-19). However, about 5% become critically ill and require intensive care treatment. Acute hypoxemic failure with severe dyspnea and an increased respiratory rate (>30/min) usually leads to ICU admission. At that point, bilateral pulmonary infiltrates are typically seen. Patients often develop a severe acute respiratory distress syndrome (ARDS). To date there is no specific treatment available-the main goal of supportive therapy is to ascertain adequate oxygenation. Early intubation and repeated prone positioning are key elements in treating hypoxemic COVID-19 patients. Strict adherence to basic infection control measures (including hand hygiene) and use of personal protection equipment (PPE) are essential in the care of patients. Procedures that lead to formation of aerosols should be avoided where possible and carried out with utmost precaution.","Med Klin Intensivmed Notfmed","Kluge, Stefan","Janssens, Uwe","Welte, Tobias","Weber-Carstens, Steffen","Marx, Gernot","Karagiannidis, Christian","32291505"],"abstract":["Since December 2019, a novel coronavirus (severe acute respiratory syndrome-coronavirus 2, SARS-CoV-2) has rapidly spread around the world resulting in an acute respiratory illness pandemic. The majority of patients presents with mild symptoms of coronavirus disease 2019 (COVID-19). However, about 5% become critically ill and require intensive care treatment. Acute hypoxemic failure with severe dyspnea and an increased respiratory rate (>30/min) usually leads to ICU admission. At that point, bilateral pulmonary infiltrates are typically seen. Patients often develop a severe acute respiratory distress syndrome (ARDS). To date there is no specific treatment available-the main goal of supportive therapy is to ascertain adequate oxygenation. Early intubation and repeated prone positioning are key elements in treating hypoxemic COVID-19 patients. Strict adherence to basic infection control measures (including hand hygiene) and use of personal protection equipment (PPE) are essential in the care of patients. Procedures that lead to formation of aerosols should be avoided where possible and carried out with utmost precaution."],"journal":"Med Klin Intensivmed Notfmed","authors":["Kluge, Stefan","Janssens, Uwe","Welte, Tobias","Weber-Carstens, Steffen","Marx, Gernot","Karagiannidis, Christian"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291505","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s00063-020-00689-w","keywords":["ARDS","Acute respiratory failure","COVID-19","Coronavirus","High-flow nasal cannula"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"locations":["German"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"_version_":1664266295638491136,"score":189.40659},{"pmid":32276097,"title":"Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery.","text":["Which Melbourne metropolitan areas are vulnerable to COVID-19 based on age, disability and access to health services? Using spatial analysis to identify service gaps and inform delivery.","Ageing adults (65+) with disability are especially vulnerable to COVID-19 and upon contracting, are a cohort most likely to require palliative care. Therefore, it is very important that health services - particularly health services providing palliative care - are proximately available. Treating the Melbourne metropolitan area as a case-study, a spatial analysis was conducted to clarify priority areas with a significantly high percentage and number of ageing adults (65+) with disability, and high barriers to accessing primary health services. After, travel times from priority areas to (i) palliative medicine, and (ii) hospital services were calculated. The geographic dispersion of areas with people vulnerable to COVID-19 with poor access to palliative care and health services are clarified. Unique methods of health service delivery are required to ensure that vulnerable populations in under-serviced metropolitan areas receive prompt and adequate care. The spatial methodology employed can be implemented in different contexts to support evidence-based COVID-19 and pandemic palliative care service decisions.","J Pain Symptom Manage","Lakhani, Ali","32276097"],"abstract":["Ageing adults (65+) with disability are especially vulnerable to COVID-19 and upon contracting, are a cohort most likely to require palliative care. Therefore, it is very important that health services - particularly health services providing palliative care - are proximately available. Treating the Melbourne metropolitan area as a case-study, a spatial analysis was conducted to clarify priority areas with a significantly high percentage and number of ageing adults (65+) with disability, and high barriers to accessing primary health services. After, travel times from priority areas to (i) palliative medicine, and (ii) hospital services were calculated. The geographic dispersion of areas with people vulnerable to COVID-19 with poor access to palliative care and health services are clarified. Unique methods of health service delivery are required to ensure that vulnerable populations in under-serviced metropolitan areas receive prompt and adequate care. The spatial methodology employed can be implemented in different contexts to support evidence-based COVID-19 and pandemic palliative care service decisions."],"journal":"J Pain Symptom Manage","authors":["Lakhani, Ali"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32276097","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jpainsymman.2020.03.041","keywords":["COVID-19","GIS","disability","health service access","palliative care","spatial analysis"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663712077970145280,"score":186.17184},{"pmid":32286679,"title":"COVID-19 challenge for modern medicine.","text":["COVID-19 challenge for modern medicine.","Coronaviruses cause disease in animals and people around the world. Human coronaviruses (HCoV) are mainly known to cause infections of the upper and lower respiratory tract but the symptoms may also involve the nervous and digestive systems. Since the beginning of December 2019, there has been an epidemic of SARS-CoV-2, which was originally referred to as 2019-nCoV. The most common symptoms are fever and cough, fatigue, sputum production, dyspnea, myalgia, arthralgia or sore throat, headache, nausea, vomiting or diarrhea (30%). The best prevention is to avoid exposure. In addition, contact persons should be subjected to mandatory quarantine. COVID-19 patients should be treated in specialist centers. A significant number of patients with pneumonia require passive oxygen therapy. Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases. A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients. Extracorporeal membrane oxygenation is a highly specialized method, available only in selected centers and not applicable to a significant number of cases. Specific pharmacological treatment for COVID-19 is not currently available. Modern medicine is gearing up to fight the new coronavirus pandemic. The key is a holistic approach to the patient including, primarily, the use of personal protective equipment to reduce the risk of further virus transmission, as well as patient management, which consists in both quarantine and, in the absence of specific pharmacological therapy, symptomatic treatment.","Cardiol J","Dzieciatkowski, Tomasz","Szarpak, Lukasz","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Smereka, Jacek","32286679"],"abstract":["Coronaviruses cause disease in animals and people around the world. Human coronaviruses (HCoV) are mainly known to cause infections of the upper and lower respiratory tract but the symptoms may also involve the nervous and digestive systems. Since the beginning of December 2019, there has been an epidemic of SARS-CoV-2, which was originally referred to as 2019-nCoV. The most common symptoms are fever and cough, fatigue, sputum production, dyspnea, myalgia, arthralgia or sore throat, headache, nausea, vomiting or diarrhea (30%). The best prevention is to avoid exposure. In addition, contact persons should be subjected to mandatory quarantine. COVID-19 patients should be treated in specialist centers. A significant number of patients with pneumonia require passive oxygen therapy. Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases. A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients. Extracorporeal membrane oxygenation is a highly specialized method, available only in selected centers and not applicable to a significant number of cases. Specific pharmacological treatment for COVID-19 is not currently available. Modern medicine is gearing up to fight the new coronavirus pandemic. The key is a holistic approach to the patient including, primarily, the use of personal protective equipment to reduce the risk of further virus transmission, as well as patient management, which consists in both quarantine and, in the absence of specific pharmacological therapy, symptomatic treatment."],"journal":"Cardiol J","authors":["Dzieciatkowski, Tomasz","Szarpak, Lukasz","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Smereka, Jacek"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286679","week":"202016|Apr 13 - Apr 19","doi":"10.5603/CJ.a2020.0055","keywords":["COVID-19","SARS-CoV-2","coronavirus","epidemiology","healthcare","medical stuff","pandemic","symptoms","treatment"],"source":"PubMed","topics":["Diagnosis","Prevention","Treatment"],"weight":1,"locations":["myalgia","arthralgia","headache","diarrhea"],"_version_":1664071627122409473,"score":166.76944},{"pmid":32283219,"pmcid":"PMC7151239","title":"Rapid Implementation of Inpatient Telepalliative Medicine Consultations during COVID-19 Pandemic.","text":["Rapid Implementation of Inpatient Telepalliative Medicine Consultations during COVID-19 Pandemic.","As COVID-19 cases increase throughout the country and healthcare systems grapple with the need to decrease provider exposure and minimize personal protective equipment (PPE) use while maintaining high quality patient care, our specialty is called upon to consider new methods of delivering inpatient palliative care. Telepalliative medicine has been used to great effect in outpatient and home-based palliative care, but has had fewer applications in the inpatient setting. As we plan for decreased provider availability due to quarantine and redeployment and seek to reach increasingly isolated hospitalized patients in the face of COVID-19, the need for telepalliative medicine in the inpatient setting is now clear. We describe our rapid and ongoing implementation of telepalliative medicine consultation for our inpatient palliative care teams and discuss lessons learned and recommendations for programs considering similar care models.","J Pain Symptom Manage","Humphreys, Jessi","Schoenherr, Laura","Elia, Giovanni","Saks, Naomi Tzril","Brown, Chelsea","Barbour, Susan","Pantilat, Steven Z","32283219"],"abstract":["As COVID-19 cases increase throughout the country and healthcare systems grapple with the need to decrease provider exposure and minimize personal protective equipment (PPE) use while maintaining high quality patient care, our specialty is called upon to consider new methods of delivering inpatient palliative care. Telepalliative medicine has been used to great effect in outpatient and home-based palliative care, but has had fewer applications in the inpatient setting. As we plan for decreased provider availability due to quarantine and redeployment and seek to reach increasingly isolated hospitalized patients in the face of COVID-19, the need for telepalliative medicine in the inpatient setting is now clear. We describe our rapid and ongoing implementation of telepalliative medicine consultation for our inpatient palliative care teams and discuss lessons learned and recommendations for programs considering similar care models."],"journal":"J Pain Symptom Manage","authors":["Humphreys, Jessi","Schoenherr, Laura","Elia, Giovanni","Saks, Naomi Tzril","Brown, Chelsea","Barbour, Susan","Pantilat, Steven Z"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283219","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jpainsymman.2020.04.001","keywords":["COVID-19","coronavirus","hospital medicine","inpatient","telehealth","telemedicine"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664182200869847040,"score":160.82939}]}